NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for ViroPharma Incorporated


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Changing Paradigms in Hereditary Angioedema: a Focus on Timely Diagnosis and New Therapies
2009 JUL 20 ... Diagnosis and New Therapies. This activity is supported by an educational grant from ViroPharma Incorporated. Faculty for this continuing medical education activity include the ...
Subject: Angioneurotic Edema
Price: $3.00
*
Changing Paradigms in Hereditary Angioedema: Pathophysiology, Diagnosis and Treatment
2009 JUL 13 ... in Fort Lauderdale, Florida. This activity is supported by an educational grant from ViroPharma Incorporated and is accredited for physicians. Faculty reviewers include Michael M. ...
Subject: Angioneurotic Edema
Price: $3.00
*
Clostridium difficile Infection: Strategic Approaches for Better Outcomes
2009 JUN 29 ... across the United States. This activity is supported by an educational grant from ViroPharma Incorporated and is accredited for physicians, pharmacists, and registered nurses. ...
Subject: Clostridium
Price: $3.00
*
Clostridium difficile Infection: Tracking a Virulent Pathogen
2009 AUG 24 ... Inc. (APIC) Annual Conference. This activity is supported by an educational grant from ViroPharma Incorporated. Faculty for this program are experts in infection control and ...
Subject: Clostridium
Price: $3.00
*
Hereditary Angioedema (HAE) National Surveillance Project
2009 NOV 3 ... receive a $25 Visa gift card. This activity is supported by an educational grant from ViroPharma Incorporated. RMEI is a medical education company that specializes in independent, ...
Subject: Angioneurotic Edema
Price: $3.00
*
ImmunoGen, Inc. Announces Election of Howard Pien to its Board of Directors and Other Results from its Annual Meeting of Shareholders
2009 NOV 23 ... SmithKline Beecham, at Abbott Laboratories and at Merck & Co. He is also a director of ViroPharma Incorporated and Vanda Pharmaceuticals. "ImmunoGen is transitioning to becoming an ...
Subject: ImmunoGen, Inc.
Price: $3.00
*
MicroDose Therapeutx Acquires ViroPharma Portfolio of Investigational Compounds for Treatment of Respiratory Syncytial Virus RSV
2009 NOV 23 ... of compounds for the potential treatment of respiratory syncytial virus (RSV) from ViroPharma Incorporated (Exton, PA). The lead investigational compound in the portfolio is an inhalable small ...
Subject: MicroDose Therapeutx Inc.
Price: $3.00
*
New Directions in Angioedema: a Focus on Etiologies and Clinical Approach
2009 JUN 22 ... and diagnosis of angioedema. This activity is supported by an educational grant from ViroPharma Incorporated. Timothy J. Craig, DO, Professor of Medicine and Pediatrics at the ...
Subject: Angioneurotic Edema
Price: $3.00
*
New Directions in Angioedema: a Focus on Supportive Care and Treatment Options
2009 SEP 21 ... Care and Treatment Options. This activity is supported by an educational grant from ViroPharma Incorporated. Timothy J. Craig, DO, from the Pennsylvania State University College of ...
Subject: Angioneurotic Edema
Price: $3.00
*
NPS Pharmaceuticals Appoints Dr. Colin Broom to Its Board of Directors
2009 JUL 27 ... to its board of directors. Dr. Broom is vice president and chief scientific officer of ViroPharma Incorporated. His appointment brings the number of NPS board members to seven. "Colin ...
Subject: NPS Pharmaceuticals, Inc.
Price: $3.00
*
Personalized Pharmaceutical Systems Announces Sale of Angioedema Clinical Prediction Guide to Viropharma Incorporated
2009 NOV 30 ... Systems (PPS) announced the sale of the Angioedema Clinical Prediction Guide to Viropharma Incorporated. PPS is a clinical trial enrichment and market differentiation company ...
Subject: Personalized Pharmaceutical Systems
Price: $3.00
*
Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting
2009 SEP 14 ... Company, Pharmaceuticals, Sanofi-Aventis, Therapy, Treatment, Vancocin, Vancomycin, ViroPharma Incorporated, Arlington Medical Resources; Decision Resources. This article was prepared ...
Subject: Clostridium
Price: $3.00
*
ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
2009 JUN 22 ... ViroPharma Incorporated (NASDAQ:VPHM) announced the appointment of Frank Baldino, Jr., Ph.D. to its board of ...
Subject: Biopharmaceuticals
Price: $3.00
*
ViroPharma Announces Initiation of Non-Toxigenic Clostridium Difficile Phase 1 Program
2009 AUG 17 ... ViroPharma Incorporated (NASDAQ:VPHM) announced that dosing has begun in the Phase 1 clinical trial for NTCD ...
Subject: Clostridium
Price: $3.00
*
ViroPharma Announces Support by Advisory Committee of the Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride
2009 AUG 17 ... ViroPharma Incorporated (NASDAQ:VPHM) announced that the Pharmaceutical Science and Clinical Pharmacology ...
Subject: Pharmaceuticals
Price: $3.00
*
ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
2009 AUG 10 ... ViroPharma Incorporated (NASDAQ:VPHM) reported its financial results for the second quarter ended June 30, 2009. ...
Subject: Biotechnology Business
Price: $3.00
*
ViroPharma to Present at Four Additional Healthcare Conferences
2009 SEP 28 ... ViroPharma Incorporated (NASDAQ:VPHM) announced that the company will be presenting at several upcoming ...
Subject: Biotechnology Business
Price: $3.00
*
ViroPharma to Present at Several Upcoming Healthcare Conferences
2009 SEP 14 ... ViroPharma Incorporated (NASDAQ:VPHM) announced that the company will be presenting in four upcoming healthcare ...
Subject: Biotechnology Business
Price: $3.00
*
ViroPharma to Present at Three November Healthcare Conferences
2009 NOV 9 ... ViroPharma Incorporated (NASDAQ:VPHM) announced that the company will be presenting at several upcoming ...
Subject: Biotechnology Business
Price: $3.00
*
ViroPharma to Present at Two June Healthcare Conferences
2009 JUN 15 ... ViroPharma Incorporated (NASDAQ:VPHM) announced that Colin Broom, MD, vice president and chief scientific ...
Subject: Pharmaceuticals
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login